Search Results
Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of
Search for other papers by Gahee Park in
Google Scholar
PubMed
Search for other papers by Tae Hyuk Kim in
Google Scholar
PubMed
Search for other papers by Hae-Ock Lee in
Google Scholar
PubMed
Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of
Search for other papers by Jung Ah Lim in
Google Scholar
PubMed
Search for other papers by Jae-Kyung Won in
Google Scholar
PubMed
Search for other papers by Hye Sook Min in
Google Scholar
PubMed
Search for other papers by Kyu Eun Lee in
Google Scholar
PubMed
Search for other papers by Do Joon Park in
Google Scholar
PubMed
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of
Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of
Search for other papers by Woong-Yang Park in
Google Scholar
PubMed
evaluated first. More importantly, a practical diagnostic assay for identifying rearrangements of ALK in thyroid cancer is essential. As is the case with non-small cell lung cancer (NSCLC), immunohistochemistry (IHC) may be a useful tool for screening for
Department of Endocrinology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
Search for other papers by Ziwei Zhang in
Google Scholar
PubMed
Search for other papers by Menglian Li in
Google Scholar
PubMed
Search for other papers by Jianjun Wang in
Google Scholar
PubMed
Search for other papers by Mengsi Liu in
Google Scholar
PubMed
Search for other papers by Huan Chen in
Google Scholar
PubMed
Search for other papers by Yuan Lou in
Google Scholar
PubMed
Search for other papers by Yijie Wang in
Google Scholar
PubMed
Search for other papers by Qi Sun in
Google Scholar
PubMed
Search for other papers by Dalong Zhu in
Google Scholar
PubMed
Search for other papers by Ping Li in
Google Scholar
PubMed
Department of Endocrinology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
Search for other papers by Yan Bi in
Google Scholar
PubMed
contrast, Fay et al. (2015) employed immunohistochemistry to show PD-L1 expression in only 11% of ACC cases; overall, the expression of PD-L1 did not correlate with tumor stage, excessive hormone secretion or 5-year survival rate. Despite these
Search for other papers by Takuya Mikoshiba in
Google Scholar
PubMed
Search for other papers by Mariko Sekimizu in
Google Scholar
PubMed
Search for other papers by Shin Saito in
Google Scholar
PubMed
Search for other papers by Shintaro Nakamura in
Google Scholar
PubMed
Search for other papers by Ryoto Nagai in
Google Scholar
PubMed
Search for other papers by Miho Kawaida in
Google Scholar
PubMed
Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Shinanomachi, Shinjuku-ku, Tokyo, Japan
Search for other papers by Isao Kurihara in
Google Scholar
PubMed
Department of Endocrinology, Metabolism and Nephrology, NHO Tokyo Medical Center, Higashigaoka, Meguro-ku, Tokyo, Japan
Search for other papers by Sakiko Kobayashi in
Google Scholar
PubMed
Search for other papers by Hiroyuki Ozawa in
Google Scholar
PubMed
et al. 1988 ). Immunohistochemistry Immunohistochemistry for ACTH was performed on tumor samples from 15 patients with ONB to evaluate whether the tumor cells expressed ACTH. Surgically resected recurrent and metastatic tumors were also
Search for other papers by Noriko Kimura in
Google Scholar
PubMed
Search for other papers by Ryoichi Takayanagi in
Google Scholar
PubMed
Search for other papers by Nae Takizawa in
Google Scholar
PubMed
Search for other papers by Eiji Itagaki in
Google Scholar
PubMed
Search for other papers by Takayuki Katabami in
Google Scholar
PubMed
Search for other papers by Narihiko Kakoi in
Google Scholar
PubMed
Search for other papers by Hiromi Rakugi in
Google Scholar
PubMed
Search for other papers by Yukihiro Ikeda in
Google Scholar
PubMed
Search for other papers by Akiyo Tanabe in
Google Scholar
PubMed
Search for other papers by Takeshi Nigawara in
Google Scholar
PubMed
Search for other papers by Sadayoshi Ito in
Google Scholar
PubMed
Search for other papers by Itaru Kimura in
Google Scholar
PubMed
Search for other papers by Mitsuhide Naruse in
Google Scholar
PubMed
Search for other papers by The Phaeochromocytoma Study Group in Japan in
Google Scholar
PubMed
immunohistochemistry to facilitate the differential diagnosis of malignant from benign disease in PHEO/PGL. Subjects and methods Patients and tissues A total of 994 patients from 178 institutes registered online. For ethical reasons, the registration was limited to
Search for other papers by Maria Cristina De Martino in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Peter M van Koetsveld in
Google Scholar
PubMed
Search for other papers by Fadime Dogan in
Google Scholar
PubMed
Search for other papers by Joseph A M J L Janssen in
Google Scholar
PubMed
Search for other papers by A Marlijn Waaijers in
Google Scholar
PubMed
Dipartimento di Medicina Clinica e Chirurgia Sezione di Endocrinologia, Università Federico II, Naples, Italy
Department of Pathology Erasmus Medical Center, Rotterdam and Reinier de Graaf Gasthuis, Delft, The Netherlands
Search for other papers by Claudia Pivonello in
Google Scholar
PubMed
Search for other papers by Steven W J Lamberts in
Google Scholar
PubMed
Dipartimento di Medicina Clinica e Chirurgia Sezione di Endocrinologia, Università Federico II, Naples, Italy
Department of Pathology Erasmus Medical Center, Rotterdam and Reinier de Graaf Gasthuis, Delft, The Netherlands
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Dipartimento di Medicina Clinica e Chirurgia Sezione di Endocrinologia, Università Federico II, Naples, Italy
Department of Pathology Erasmus Medical Center, Rotterdam and Reinier de Graaf Gasthuis, Delft, The Netherlands
Search for other papers by Ronald R de Krijger in
Google Scholar
PubMed
Dipartimento di Medicina Clinica e Chirurgia Sezione di Endocrinologia, Università Federico II, Naples, Italy
Department of Pathology Erasmus Medical Center, Rotterdam and Reinier de Graaf Gasthuis, Delft, The Netherlands
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
threshold method, 2−ΔCt ( Schmittgen & Livak 2008 ), after efficiency correction ( Pfaffl 2001 ) of target and reference gene transcripts ( HPRT ). Immunohistochemistry The expression of total/phospho-mTOR, total/phospho-4EBP1, and total/phospho-S6K1 in
Search for other papers by Anela Blažević in
Google Scholar
PubMed
Search for other papers by Anand M Iyer in
Google Scholar
PubMed
Search for other papers by Marie-Louise F van Velthuysen in
Google Scholar
PubMed
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Search for other papers by Gaston J H Franssen in
Google Scholar
PubMed
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Marina Zajec in
Google Scholar
PubMed
Search for other papers by Theo M Luider in
Google Scholar
PubMed
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Leo J Hofland in
Google Scholar
PubMed
% FDR at the peptide level. FDRs were estimated by inclusion of a decoy database search generated by Mascot. A Protein Report exported from Scaffold was used for data analysis. Immunohistochemistry Immunohistochemistry (IHC) was performed for
Search for other papers by Sylvia L Asa in
Google Scholar
PubMed
Search for other papers by Shereen Ezzat in
Google Scholar
PubMed
ligands (SRL). We find it fascinating that new complex technologies such as molecular profiling are confirming data that was published many years ago using routine immunohistochemistry. In 2002 and 2004, our Japanese colleagues led by Dr Toshiaki Sano
Search for other papers by Arthur S Tischler in
Google Scholar
PubMed
Department of Pathology and Laboratory Medicine, Department of Pathology, Department of Pathology, Tufts Medical Center, Tufts University School of Medicine, 800 Washington Street, Box 802, Boston, Massachusetts 02111, USA
Search for other papers by Ronald R deKrijger in
Google Scholar
PubMed
). Immunohistochemistry is used as an aid to diagnosis in challenging cases, with the immunohistochemical markers tailored to both the anatomic site and the diagnoses under consideration. As general guidelines, pheochromocytomas and paragangliomas express generic
Search for other papers by Maria Eugenia Sabatino in
Google Scholar
PubMed
Search for other papers by Juan Pablo Petiti in
Google Scholar
PubMed
Search for other papers by Liliana del Valle Sosa in
Google Scholar
PubMed
Search for other papers by Pablo Anibal Pérez in
Google Scholar
PubMed
Search for other papers by Silvina Gutiérrez in
Google Scholar
PubMed
Search for other papers by Carolina Leimgruber in
Google Scholar
PubMed
Search for other papers by Alexandra Latini in
Google Scholar
PubMed
Search for other papers by Alicia Inés Torres in
Google Scholar
PubMed
Search for other papers by Ana Lucía De Paul in
Google Scholar
PubMed
-006-0101-9 ). 16823503 Nishihara E Nagayama Y Inoue S Hiroi H Muramatsu M Yamashita S Koji T 2000 Ontogenetic changes in the expression of estrogen receptor α and β in rat pituitary gland detected by immunohistochemistry . Endocrinology 141 615
Cancer Genetics, Department of Surgery, Anatomical Pathology, Endocrinology, Endocrine and Oncology Surgery, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St Leonards, Sydney, New South Wales 2065, Australia
Search for other papers by P S H Soon in
Google Scholar
PubMed
Search for other papers by A J Gill in
Google Scholar
PubMed
Search for other papers by D E Benn in
Google Scholar
PubMed
Search for other papers by A Clarkson in
Google Scholar
PubMed
Cancer Genetics, Department of Surgery, Anatomical Pathology, Endocrinology, Endocrine and Oncology Surgery, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St Leonards, Sydney, New South Wales 2065, Australia
Search for other papers by B G Robinson in
Google Scholar
PubMed
Search for other papers by K L McDonald in
Google Scholar
PubMed
Cancer Genetics, Department of Surgery, Anatomical Pathology, Endocrinology, Endocrine and Oncology Surgery, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St Leonards, Sydney, New South Wales 2065, Australia
Search for other papers by S B Sidhu in
Google Scholar
PubMed
tested using immunohistochemistry (IHC). Materials and methods Patients and tumors Ethics approval for the study was obtained from the Northern Sydney Area Health Service Human Research Ethics Committee. Informed consent was obtained from patients prior